BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28754571)

  • 41. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1.
    Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M
    Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression.
    Jabareen A; Abu-Jaafar A; Abou-Kandil A; Huleihel M
    Cell Cycle; 2017 Jul; 16(14):1336-1344. PubMed ID: 28594273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling.
    Nehybova T; Smarda J; Daniel L; Brezovsky J; Benes P
    J Steroid Biochem Mol Biol; 2015 Aug; 152():76-83. PubMed ID: 25934092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities.
    Larrosa M; González-Sarrías A; García-Conesa MT; Tomás-Barberán FA; Espín JC
    J Agric Food Chem; 2006 Mar; 54(5):1611-20. PubMed ID: 16506809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
    Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
    Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
    Kostelac D; Rechkemmer G; Briviba K
    J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells.
    Wu F; Safe S
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):1-9. PubMed ID: 17141713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus.
    Hewitt SC; Collins J; Grissom S; Hamilton K; Korach KS
    Endocrinology; 2006 May; 147(5):2203-14. PubMed ID: 16469803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin.
    del Río B; García Pedrero JM; Martínez-Campa C; Zuazua P; Lazo PS; Ramos S
    J Biol Chem; 2004 Sep; 279(37):38294-302. PubMed ID: 15229223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms.
    Fujiki N; Konno H; Kaneko Y; Gohno T; Hanamura T; Imami K; Ishihama Y; Nakanishi K; Niwa T; Seino Y; Yamaguchi Y; Hayashi S
    J Steroid Biochem Mol Biol; 2014 Jan; 139():61-72. PubMed ID: 24128438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Classification of different types of estrogen receptor alpha binding sites in MCF-7 cells.
    Bojcsuk D; Bálint BL
    J Biotechnol; 2019 Jun; 299():13-20. PubMed ID: 31039369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.
    Evers NM; van den Berg JH; Wang S; Melchers D; Houtman R; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental and computational insights on the recognition mechanism between the estrogen receptor α with bisphenol compounds.
    Cao H; Wang F; Liang Y; Wang H; Zhang A; Song M
    Arch Toxicol; 2017 Dec; 91(12):3897-3912. PubMed ID: 28616630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of estrogen receptor transactivation and estrogen-induced gene expression by ormeloxifene-a triphenylethylene derivative.
    Blesson CS; Awasthi S; Kharkwal G; Daverey A; Dwivedi A
    Steroids; 2006 Nov; 71(11-12):993-1000. PubMed ID: 16965798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.